Study testing a new valve delivered through a blood vessel
Part of Heart & circulation clinical trials.
This trial studies Prizvalve Pro™, a new transcatheter (catheter-based) aortic valve replacement, for people with severe aortic valve narrowing who are too high-risk for standard surgery. It may help your heart work better and improve symptoms by replacing the failing valve without open-heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 65 or older
- Have severe aortic valve stenosis with symptoms, based on heart ultrasound measurements
- Have heart function class NYHA II or higher and life expectancy over 12 months
- Have heart anatomy that fits this catheter valve procedure
- Be considered unsuitable for standard surgery by heart surgeons, or refuse surgery because it’s high risk
- Be able to understand the study, sign consent, and come for follow-up tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows how the VitaFlow heart valve works in people age 70+ who have severe, narrowed aortic valves and cannot safely get open-heart valve surgery. It’s meant to see whether the device improves outcomes and is safe over time.
This trial tests a new delivery system (VitaFlow Liberty Flex) for placing a replacement aortic valve in people with severe aortic stenosis. It is designed for patients whose heart anatomy (a steep angle between the heart and aorta) makes the procedure more challenging.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial tests a new type of aortic heart valve (PoliaValve) for people with severe aortic valve disease who need valve replacement surgery. If you qualify, you will receive the experimental valve and be followed for one year to see how well it works.
This study tracks patients getting a new heart valve (transcatheter aortic valve implantation) for severe aortic stenosis. It aims to understand long-term outcomes and safety in a real-world registry.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.